| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | JYB41CTM2Q |
| InChI Key | TVZGACDUOSZQKY-LBPRGKRZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H20N8O5 |
| Molecular Weight | 440.42 |
| AlogP | 0.24 |
| Hydrogen Bond Acceptor | 10.0 |
| Hydrogen Bond Donor | 6.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 219.33 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 32.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Ligase
|
- | - | - | 17600 | - | |
|
Enzyme
Oxidoreductase
|
- | 2-35 | - | 0-0 | - | |
|
Enzyme
Protease
Metallo protease
Metallo protease MAE clan
Metallo protease M27 family
|
- | - | - | - | 11 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 125 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054198 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Psoriasis | 2 | D011565 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 54-62-6 |
| ChEBI | 22526 |
| ChEMBL | CHEMBL376180 |
| DrugBank | DB08878 |
| DrugCentral | 21 |
| EPA CompTox | DTXSID3022588 |
| FDA SRS | JYB41CTM2Q |
| PDB | 04J |
| PubChem | 169371 |
| SureChEMBL | SCHEMBL1626034 |
| ZINC | ZINC000002036915 |